Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/01/2012EP2480256A2 Chemically amplified response strategies for medical sciences
08/01/2012EP2480255A1 Therapy for enteric infections
08/01/2012EP2480254A2 Insulin receptor binding antibodies
08/01/2012EP2480253A1 Adsorption of immunopotentiators to insoluble metal salts
08/01/2012EP2480252A1 Methods, compositions, and kits for reducing anti-antibody responses
08/01/2012EP2480251A1 Carrier conjugates of il-23-peptides and their induced antibodies
08/01/2012EP2480241A1 Bacterial spore having therapeutic agent adsorbed on its surface
08/01/2012EP2480240A1 Modified gram-negative bacteria for use as vaccines
08/01/2012EP2288619B8 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals
08/01/2012EP2235046B1 Mutant forms of streptolysin o
08/01/2012EP2167124B1 The use of monomycolyl glycerol (mmg) as an adjuvant
08/01/2012EP1948782B1 Vaccine adjuvants
08/01/2012EP1940465B1 Novel use of anti il-1beta antibodies
08/01/2012EP1921146B1 Recombinant vectors based on the modified ankara virus (mva) as preventive and therapeutic vaccines against aids
08/01/2012EP1885337B1 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous
08/01/2012EP1853310B1 Anti a beta antibody formulation
08/01/2012EP1771552B1 Influenza hemagglutinin and neuraminidase variants
08/01/2012EP1747015B1 Solution phase biopanning method using engineered decoy proteins
08/01/2012EP1728864B1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
08/01/2012EP1633395B1 Functionally reconstituted viral membranes containing adjuvant
08/01/2012EP1581242B1 Compositions and methods for modifying toxic effects of proteinaceous compounds
08/01/2012EP1553966B1 Fusion peptides comprising the human papillomavirus e7 and e6 polypeptides and immunogenic compositions thereof
08/01/2012EP1346049B1 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012EP1181057B1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
08/01/2012EP1133310B1 Artery- and vein-specific proteins and uses therefor
08/01/2012CN102625813A Immunoglobulins with reduced aggregation
08/01/2012CN102625714A HIV vaccine based on targeting maximized Gag and Nef to dendritic cells
08/01/2012CN102625713A Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
08/01/2012CN102618557A Recombinant avian flavivirus E protein and application thereof
08/01/2012CN102618508A Recombinant porcine pseudorabies virus, as well as construction method and application thereof
08/01/2012CN102618504A Bivalent vaccine for hemorrhagic fever with renal syndrome and its preparation method
08/01/2012CN102618503A Hybrid tumor cell strain 1D7 capable of secreting high neutralizing activity canine distemper virus monoclonal antibody
08/01/2012CN102618453A Apx I C gene deleted mutant strain of porcine infectious actinobacillus pleuropneumonia, construction method, vaccine and application
08/01/2012CN102617739A Novel method for preventing or treating M tuberculosis infection
08/01/2012CN102617735A Antibodies against human IL17 and uses thereof
08/01/2012CN102617734A Antibody Dab-2 against FGF-2 and application thereof
08/01/2012CN102617733A Antibodies directed against amyloid-beta peptide and methods using same
08/01/2012CN102617731A Porcine circovirus-resistant type 2 egg yolk antibody, and preparation method and application thereof
08/01/2012CN102617726A Recombinant horse allergen and mutant and preparation methods and applications thereof
08/01/2012CN102617719A Recombinant rice allergen and mutant and preparation methods and applications thereof
08/01/2012CN102617715A Recombinant fungus major allergen and mutant and preparation methods and applications thereof
08/01/2012CN102617712A Polypeptide for effectively restraining activity of influenza virus polymerase
08/01/2012CN102614527A Antiacid nano oral deoxyribonucleic acid (DNA) anti-tumor vaccine with potential of hydrogen (pH) sensitive characteristic and preparation method
08/01/2012CN102614526A Cross-protection DNA vaccine
08/01/2012CN102614513A Application of anti-angiohemophilia factor A3 zone bifunctional monoclonal antibody
08/01/2012CN102614512A Multiple-variable dose regimen for treating TNFalpha-related disorders
08/01/2012CN102614511A Propolis-adjuvant inactivated vaccine for mink pasteurellosis
08/01/2012CN102614510A Yeast-based therapeutic for chronic hepatitis C infection
08/01/2012CN102614509A Preparation method of orally-taken vaccine for treatment of hemorrhage of grass carp
08/01/2012CN102614508A Virus split deactivation method for human influenza virus split vaccine
08/01/2012CN102614507A Type O foot-and-mouth disease virus molecular marker vaccine and preparation method thereof
08/01/2012CN102614506A Recombinant HPV16L2 protein vaccine and preparation method thereof
08/01/2012CN102614505A Chimeric protein vaccine containing HPV16 type L1 and E7 target antigens expressed in yeast cells and its preparation method
08/01/2012CN102614504A Pseudomonas fluorescens recombinant protein vaccine and preparation method thereof
08/01/2012CN102614503A Edwardsiella tarda recombinant protein vaccines, and preparation and application thereof
08/01/2012CN101880328B Th multi-epitope gene and fusion protein of cryptosporidium parvum and application thereof
08/01/2012CN101816784B Immunoprotective subunit vaccine, preparation method thereof and application method thereof
07/2012
07/31/2012US8232379 Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
07/31/2012US8232373 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
07/31/2012US8232259 Multiple CpG oligodeoxynucleotide and their use to induce an immune response
07/31/2012US8232255 Methods for vaccinating against malaria
07/31/2012US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders
07/31/2012US8232240 Inhibitors of enveloped virus infectivity
07/31/2012US8232068 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
07/31/2012US8231894 Antimicrobial and immunostimulating composition
07/31/2012US8231881 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
07/31/2012US8231880 Simian subfamily C adenoviruses SAdV-40, -31, and -34 and uses thereof
07/31/2012US8231879 Treatment of diseases caused by viral infection
07/31/2012US8231877 Heterologous antibodies which bind human CD4
07/31/2012US8231876 Purified antibody composition
07/31/2012US8231875 Neutralising antibody molecules having specificity for human IL-17
07/31/2012US8231874 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
07/31/2012US8231873 Methods of treatment using antibodies to Neutrokine-alpha
07/31/2012US8231872 Regulatory T cell mediator proteins and uses thereof
07/31/2012US8231868 Method for suppressing immune system response to transplanted tissue or cells
07/31/2012US8231867 Dietzia bacterium for treatment of disease
07/31/2012CA2656266C Recombinant viral vaccine
07/31/2012CA2544374C Botulinum toxin treatments of neurological and neuropsychiatric disorders
07/31/2012CA2471656C Antibody against fibroblast growth factor-23
07/31/2012CA2441903C Single-domain brain-targeting antibody fragments derived from llama antibodies
07/31/2012CA2411919C Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
07/31/2012CA2404688C Nuclear factor .kappa.b inducing factor
07/31/2012CA2349217C Cancer-associated antigens and methods of their identification
07/31/2012CA2341018C Polypeptides and polynucleotides from coagulase-negative staphylococci
07/31/2012CA2272407C Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen
07/31/2012CA2223402C Methods of inhibiting phagocytosis
07/26/2012WO2012100262A1 Therapeutic method using anti - ctgf antibody
07/26/2012WO2012100234A1 Vaccines and compositions against streptococcus pneumoniae
07/26/2012WO2012100233A1 Vaccines and compositions against streptococcus pneumoniae
07/26/2012WO2012099851A2 Prenatal enzyme replacement therapy
07/26/2012WO2012099805A2 Nanoparticle based immunological stimulation
07/26/2012WO2012099566A1 Influenza virus neutralizing agents that mimic the binding site of an influenza neutralizing antibody
07/26/2012WO2012099375A2 P47phox or p67phox-targeting therapeutic agent for stress disorders, and method for screening for same
07/26/2012WO2012098465A1 Pvrl4 (nectin 4) is a receptor for measles virus
07/26/2012WO2012098089A1 Binding proteins to inhibitors of coagulation factors
07/26/2012WO2012097634A1 Medicine for treating hpv infection, and its use in preparation of pharmaceuticals for treating hpv infection
07/26/2012WO2012075361A3 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
07/26/2012WO2012071573A3 Materials and methods for the prevention and treatment of cancer
07/26/2012WO2012065072A3 IMPROVED HIGH CONCENTRATION ANTI-TNFα ANTIBODY LIQUID FORMULATIONS
1 ... 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 ... 1823